share_log

Invitation to the Presentation of Calliditas ́s Interim Report January - March 2024

Invitation to the Presentation of Calliditas ́s Interim Report January - March 2024

邀请参加2024年1月至3月Calliditas中期报告的发布会
PR Newswire ·  05/16 02:43

STOCKHOLM, May 16, 2024 /PRNewswire/ -- Calliditas's interim report for the first quarter, January - March 2024 will be published in Swedish and English on Thursday 23 May 2024 at 07.00 a.m. CET.

斯德哥尔摩,2024 年 5 月 16 日 /PRNewswire/-- Calliditas的2024年1月至3月第一季度中期报告将于欧洲中部时间2024年5月23日星期四上午7点以瑞典语和英语发布。

A combined audio cast and telephone conference with the opportunity to ask questions will be held at 14.30 p.m. CET on the same day, with CEO Renée Aguiar-Lucander and CFO Fredrik Johansson, CMO Richard Philipson and President North America Maria Törnsén.

欧洲中部时间当天下午 14:30 将举行一次有机会提问的音频和电话会议,首席执行官蕾妮·阿吉亚尔-卢坎德和首席财务官弗雷德里克·约翰逊、首席营销官理查德·菲利普森和北美总裁玛丽亚·托恩森。

The presentation will be given in English.

演讲将以英文进行。

Link to the webcast:

链接到网络直播:

Calliditas Therapeutics Q1 Report 2024 (financialhearings.com)

Calliditas Therapeutics 2024 年第一季度报告(financialhearings.com)

To participate via conference call please register via this link:

要通过电话会议参加,请通过以下链接注册:

After registration, you will receive a phone number and a conference ID to log in to the conference call. Via the telephone conference, there is an opportunity to ask oral questions.

注册后,您将收到一个电话号码和一个会议 ID,用于登录电话会议。通过电话会议,有机会提出口头问题。

For further information, please contact:

欲了解更多信息,请联系:

Åsa Hillsten, Head of IR & Sustainability, Calliditas

Asa Hillsten,Calliditas 投资者关系与可持续发展主管

Tel. +46 76 403 35 43, Email: [email protected]

电话:+46 76 403 35 43,电子邮件:[email protected]

The information was sent for publication, through the agency of the contact person set out above, on 16 May, 2024, at 8:30 a.m. CET.

该信息已于欧洲中部时间2024年5月16日上午 8:30 通过上述联系人的代理机构发送出版。

This information was brought to you by Cision

这些信息是由 Cision 带给你的

The following files are available for download:

以下文件可供下载:

Invitation to the presentation of Calliditas_Q1 2024

邀请参加 Calliditas_Q1 2024 演讲

SOURCE Calliditas Therapeutics

来源 Calliditas 疗法

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发